"This commitment has proven to be a great success – with the adoption of this program by more than half of the leading global biotech and pharmaceutical corporations’ use of our BioPharma Exchange as part of their ongoing surplus asset management process."
"While this is a great achievement, we are pushing forward with our plans to expand the global reach of the Exchange program," said Randy Small, VP of Asset Sales & Services, North America. "In the beginning, the BioPharma Exchange program’s buyer bases were regional companies and equipment service providers. Since then, the program has dramatically expanded; its buyers include mainstream organizations across the world from universities and global corporations to international CRO’s (Contract Research Organizations). These organizations are consistently utilizing the Bio Exchange as their cost-effective equipment procurement channel."
The success of the BioPharma Exchange program is just another example of our commitment to providing secure and transparent marketplaces for buyers and sellers to complete their transactions. This has also reaffirmed our commitment to developing the secondary marketplace as a key and vital source for organizations to procure and sell quality equipment.
"Since the inception of the Exchange program, we have been committed to establishing an ongoing, industry-specific marketplace that provides a safe and secure sales channel for our corporate clients," stated Romie Castelli, Senior Vice President of Sales, North America. "This commitment has proven to be a great success – with the adoption of this program by more than half of the leading global biotech and pharmaceutical corporations’ use of our BioPharma Exchange as part of their ongoing surplus asset management process."
The Exchange program has become a key destination for customers looking to acquire equipment. This achievement further demonstrates GoIndustry DoveBid’s commitment to the following:
For Buyers:
For Sellers: